![](/img/cover-not-exists.png)
549 Results of a prospective phase I/II randomized trial of peptide-specific vaccination in HLA-A*0201 positive prostate carcinoma patients with biochemical recurrence after radical prostatectomy
Bedke, J., Gouttefangeas, C., Feyerabend, S., Hennenlotter, J., Avilés Escobar, C.M., Laske, K., Widenmeyer, M., Griesemann, H., Stevanovic, S., Rammensee, H-G., Stenzl, A.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60551-1
Date:
March, 2016
File:
PDF, 107 KB
english, 2016